aTYR PHARMA ATYR
NASDAQ ATYR
$0.17 0.00 (-0.58%)
At close: Oct 21, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) Current Deferred Revenue (2019 - 2020)

Updated

aTYR PHARMA's Current Deferred Revenue came in at $53,000 for Q3 2020, down 84.9% from $352,000 a year earlier and down 73.6% from the prior quarter.

Analysis

aTYR PHARMA (ATYR) Current Deferred Revenue (2019 - 2020) Analysis & Trends

At the end of FY2019, aTYR PHARMA's Current Deferred Revenue was $208,000.

  • Year-over-year, Current Deferred Revenue has declined for three consecutive quarters.
  • Business Quant data shows ATYR's Current Deferred Revenue at $201,000 (Q2 2020), $143,000 (Q1 2020) and $208,000 (Q4 2019) in the three quarters before Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 aTYR PHARMA 16.81 Mn -276.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 53,000.00
Jun 30, 2020 201,000.00
Mar 31, 2020 143,000.00
Dec 31, 2019 208,000.00
Sep 30, 2019 352,000.00
Jun 30, 2019 536,000.00
Mar 31, 2019 630,000.00
API Access

aTYR PHARMA Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ATYR&period=max&api_key=YOUR_API_KEY